about
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesHigh-Throughput Approaches to the Development of Molecular Imaging Agents.Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.Combinatorial peptide libraries: mining for cell-binding peptides.Biopanning of phage displayed peptide libraries for the isolation of cell-specific ligandsGeneration of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo.Potential of phage-displayed peptide library technology to identify functional targeting peptidesBiodistribution and SPECT imaging study of (99m)Tc labeling NGR peptide in nude mice bearing human HepG2 hepatomaPeptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.In vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective.Effects of parenteral nutrition on the exocrine pancreas in response to cholecystokinin.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Advances in beta-cell imagingAdvances in molecular imaging of pancreatic beta cellsMolecular imaging: a promising tool to monitor islet transplantation.Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells.Discontinuous epitope prediction based on mimotope analysis.
P2860
Q26995399-0E2F9C46-8121-474C-B7F8-1BACC8925E97Q30275493-B923F3A7-42E7-48CC-81D0-3F3FC67BA727Q30391507-78F3C302-6342-44CB-9EC2-AD0CD84C8CB8Q31144876-A146E30F-F100-40F0-BE83-C8E4E7762AC5Q33401626-5BBC3D0F-7C08-4F25-9EC1-31A19E5307BAQ33480823-10D82547-450D-4BA3-849E-7AD5138C4010Q33530848-568AD74E-B4B1-4FF4-A753-2DE70A266ACDQ33737365-A0CE658A-6126-4E76-BC50-31A927E35CA7Q35783096-80E39917-943E-4E3D-AD67-4C5BA62D9BC6Q36773604-B087A981-327D-41D9-93CA-2528AF446F0DQ37047555-2D9A417A-9D3C-4814-872E-8CEB4F54D09DQ37346447-64440009-07D5-4BBB-A93D-67F70EDBDB04Q37406437-BE339F83-3222-42EC-8F39-0ADE22CA9CA2Q37466693-937A9C8E-B7F7-4871-A3FB-E34628135120Q37947597-65C9F746-D39B-4DE3-A2D0-39FFF034D1DDQ39012287-70C2C4DC-D332-42B0-87D4-0F5D18737140Q48459743-7FCD0C11-8FE3-4390-8310-0355051DAAFD
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Peptide-mediated targeting of the islets of Langerhans.
@ast
Peptide-mediated targeting of the islets of Langerhans.
@en
type
label
Peptide-mediated targeting of the islets of Langerhans.
@ast
Peptide-mediated targeting of the islets of Langerhans.
@en
prefLabel
Peptide-mediated targeting of the islets of Langerhans.
@ast
Peptide-mediated targeting of the islets of Langerhans.
@en
P2093
P1433
P1476
Peptide-mediated targeting of the islets of Langerhans.
@en
P2093
Christopher B Newgard
Kathlynn C Brown
Kausar N Samli
Michael J McGuire
Stephen Albert Johnston
P304
P356
10.2337/DIABETES.54.7.2103
P407
P577
2005-07-01T00:00:00Z